Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Curr Med Chem ; 20(1): 134-43, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23033946

RESUMEN

Prevention of amyloidosis by chemical compounds is a potential therapeutic strategy in Alzheimer's, prion and other neurodegenerative diseases. Regularly branched dendrimers and less regular hyperbranched polymers have been suggested as promising inhibitors of amyloid aggregation. As demonstrated in our previous studies, some widely used dendrimers (PAMAM, PPI) could not only inhibit amyloid aggregation in solution but also dissolve mature fibrils. In this study we have performed computer simulation of polylysine dendrimers of 3rd and 5th generations (D3 and D5) and analysed the effect of these dendrimers and some hyperbranched polymers on a lysine base (HpbK) on aggregation of amyloid peptide in solution. The effects of dendrimers on cell viability and their protective action against Aß-induced cytotoxicity and alteration of K+channels was also analysed using human neuroblastoma SH-SY5Y cells. In addition, using fluorescence microscopy, we analysed uptake of FITC-conjugated D3 by SH-SY5Y cells and its distribution in the brain after intraventricular injections to rats. Our results demonstrated that dendrimers D3 and D5 inhibited amyloid aggregation in solution while HpbK enhanced amyloid aggregation. Cell viability and patch-clamp studies have shown that D3 can protect cells against Aß-induced cytotoxicity and K+channel modulation. In contrast, HpbK had no protective effect against Aß. Fluorescence microscopy studies demonstrated that FITC-D3 accumulates in the vacuolar compartments of the cells and can be detected in various brain structures and populations of cells after injections to the brain. As such, polylysine dendrimers D3 and D5 can be proposed as compounds for developing antiamyloidogenic drugs.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Dendrímeros/química , Dendrímeros/farmacología , Neuronas/efectos de los fármacos , Polilisina/química , Polilisina/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/toxicidad , Animales , Encéfalo/metabolismo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Dendrímeros/farmacocinética , Humanos , Modelos Moleculares , Neuronas/citología , Neuronas/patología , Técnicas de Placa-Clamp , Polilisina/farmacocinética , Ratas
3.
Scand J Clin Lab Invest ; 62(3): 231-6, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12088342

RESUMEN

Four spectrophotometric methods of determination of antioxidant capacity: a method based on the scavenging of the l,1-diphenyl-2-picrylhydrazyl (DPPH) free radical, the "ferric-reducing ability of plasma" (FRAP), a method based on reduction of the 2.2'-azinobis (3-ethylbenzthiazolinesulfonate) free radical (ABTS.+) and a kinetic method based on the oxidation of dihydro-2,7-dichlorofluorescein by 2,2'-azobis(2-amidopropane) (ABAP) were compared with respect to standard antioxidants (ascorbate, glutathione, Trolox and urate) and human blood plasma. Various reactivities of standard antioxidants in different tests were found. glutathione showing a low reactivity in the FRAP assay. Kinetic measurements show that the reduction of indicators, especially by blood plasma, may not be complete at recommended times of the assays and the time of measurement is an important parameter when comparing the results.


Asunto(s)
Antioxidantes/análisis , Química Clínica/métodos , Plasma/química , Espectrofotometría/métodos , Adulto , Amidinas , Antioxidantes/metabolismo , Ácido Ascórbico/análisis , Ácido Ascórbico/sangre , Benzotiazoles , Compuestos de Bifenilo , Femenino , Glutatión/análisis , Glutatión/sangre , Humanos , Cinética , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Picratos , Ácidos Sulfónicos , Ácido Úrico/análisis , Ácido Úrico/sangre
4.
Biochem Mol Biol Int ; 46(3): 519-28, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9818091

RESUMEN

A simple spectrophotometric method of determination of peroxyl radical-trapping capacity (PRTC) of body fluids and food products is proposed. In this method, decomposition of 2,2'-azobis(2-amidopropane) hydrochloride (ABAP) is the source of peroxyl and alkoxyl radicals which oxidize 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) to a green cation radical. Antioxidant present in a sample inhibit the reaction; the induction time of the reaction is proposed as a parameter enabling determination of antioxidant content. Standard assay conditions are: 20 mM ABAP and 150 microM ABTS in 0.1 M phosphate buffer, pH 7.0, at 37 degrees C; absorbance is monitored at 414 nm. A 10-min assay allows for determination of the induction time of appropriately diluted sample. As examples of application of this method, PRTC values of several types of beverages are reported.


Asunto(s)
Antioxidantes/análisis , Peróxidos/metabolismo , Ácidos Sulfónicos/metabolismo , Bebidas Alcohólicas , Amidinas/metabolismo , Aminoácidos/farmacología , Antioxidantes/farmacología , Ácido Ascórbico/análisis , Ácido Ascórbico/farmacología , Benzotiazoles , Cromanos/análisis , Cromanos/farmacología , Epinefrina/farmacología , Radicales Libres , Indicadores y Reactivos , Oxidación-Reducción , Plasma , Espectrofotometría , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...